Wendy Yarno

Wendy L.
Yarno is currently an Independent Director at Inovio Pharmaceuticals, Inc. since 2017, an Independent Director at IDEAYA Biosciences, Inc. since 2019, and the Lead Independent Director at Tarsus Pharmaceuticals, Inc. since 2022.
Former positions include Non-Executive Chairman at Aratana Therapeutics, Inc. from 2015 to 2019, Independent Director at St. Jude Medical LLC from 2011 to 2017, Director at PluroGen Therapeutics, Inc. from 2010 to 2014, Director at Adial Pharmaceuticals, Inc. from 2009 to 2014, Independent Director at MyoKardia, Inc. from 2017 to 2020, Independent Director at Medivation LLC (California) from 2013 to 2016, Independent Director at Lundbeck Seattle BioPharmaceuticals, Inc., Director at Durata Therapeutics, Inc. in 2014, Independent Director at Global Blood Therapeutics, Inc. from 2017 to 2022, Independent Director at Iovance Biotherapeutics, Inc. from 2023 to 2026, Vice President-Women's Health Care Franchise at Johnson & Johnson from 1997 to 1998, Chief Marketing Officer & Executive Vice President at Merck & Co., Inc. from 1999 to 2008, Chief Marketing Officer at HemoShear Therapeutics, Inc. from 2010 to 2011, and Vice President-Women's Healthcare Franchise at Ortho-McNeil Pharmaceutical LLC.
Education includes an undergraduate degree from Portland State University in 1982 and an MBA from Fox School of Business in 1988.